Aethlon Medical, Inc. announced on September 4, 2025, the pricing of a public offering expected to generate approximately $4.5 million in gross proceeds. The offering includes an aggregate of 5,000,000 shares of common stock (or pre-funded warrants) and warrants to purchase up to 5,000,000 shares of common stock.
The combined public offering price is $0.90 per share (or pre-funded warrant) and accompanying warrant. The warrants will have an exercise price of $0.90 per share, be exercisable immediately upon issuance, and expire on the fifth anniversary of the original issuance date.
The company intends to use the net proceeds from this offering for general corporate purposes, including clinical trial expenses, research and development, capital expenditures, and working capital. The closing of the offering is expected to occur on or about September 5, 2025, subject to customary closing conditions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.